Carbopol 974P

DB05384ApprovedWithdrawnSmall molecule

Carbopol 974P is a polymer used as a lacrimal substitute to treat symptoms associated with dry eyes. Carbopol 974P is a highly carboxylated polymer composed of lightly cross-linked polyacrylic acid with a broad-spectrum mechanism based on acidification of pathogens.

Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in contraception and HIV prevention.Curator reviewed · 3 structured indications
Also known as
Carbomer 974 (P) · Carbomer 974P · Carbomer homopolymer type B · Carbomer-974P · Carbopol polymer

Resolves to

Clinical / RWD

What you can answer from here — as of April 02, 2025

4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
11Marketed productsAcross 3 countries and 3 labellers
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Carbopol 974P, and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account